MURA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Mural Oncology Plc (MURA).


$54.93M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

MURA Market Cap. (MRY)


MURA Shares Outstanding (MRY)


MURA Assets (MRY)


Total Assets

$169.39M

Total Liabilities

$28.89M

Total Investments

$28.92M

MURA Income (MRY)


Revenue

$0

Net Income

-$128.51M

Operating Expense

$138.26M

MURA Cash Flow (MRY)


CF Operations

-$128.54M

CF Investing

-$25.33M

CF Financing

$196.00K

MURA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

-

0%

-

-

2021

$0

-

-

-

-

MURA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$169,394,000 (-43.86%)

$301,745,000 (794.06%)

$33,750,000 (-3.87%)

$35,110,000

Assets Current

$152,917,000 (-44.86%)

$277,337,000 (5657.46%)

$4,817,000 (13.64%)

$4,239,000

Assets Non-Current

$16,477,000 (-32.49%)

$24,408,000 (-15.64%)

$28,933,000 (-6.28%)

$30,871,000

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$140,502,000 (-46.74%)

$263,817,000 (1318.22%)

-$21,656,000 (-21.13%)

-$17,879,000

Property Plant & Equipment Net

$14,498,000 (-39.97%)

$24,150,000 (-16.53%)

$28,933,000 (-6.28%)

$30,871,000

Cash & Equivalents

$117,431,000 (-56.69%)

$271,110,000 (0%)

$0 (0%)

$0

Accumulated Other Comprehensive Income

$20,000 (0%)

$0 (0%)

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$28,923,000 (0%)

$0 (0%)

$0 (0%)

$0

Investments Current

$28,923,000 (0%)

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$2,056,000 (-65.58%)

$5,973,000 (101.38%)

$2,966,000 (-71.98%)

$10,586,000

Accumulated Retained Earnings (Deficit)

-$159,371,000 (-416.48%)

-$30,857,000

-

-

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$8,022,000 (-46.55%)

$15,009,000 (-22.58%)

$19,386,000 (-23.39%)

$25,306,000

Debt Current

$5,560,000 (-8.82%)

$6,098,000 (4.35%)

$5,844,000 (-1.28%)

$5,920,000

Debt Non-Current

$2,462,000 (-72.37%)

$8,911,000 (-34.20%)

$13,542,000 (-30.15%)

$19,386,000

Total Liabilities

$28,892,000 (-23.82%)

$37,928,000 (-31.55%)

$55,406,000 (4.56%)

$52,989,000

Liabilities Current

$26,195,000 (-9.73%)

$29,017,000 (-30.18%)

$41,560,000 (25.00%)

$33,247,000

Liabilities Non-Current

$2,697,000 (-69.73%)

$8,911,000 (-35.64%)

$13,846,000 (-29.87%)

$19,742,000

MURA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$27,596,000 (-10.13%)

$30,706,000 (73.17%)

$17,732,000 (14.05%)

$15,548,000

Research & Development Expense

$110,666,000 (-33.15%)

$165,532,000 (-0.99%)

$167,191,000 (4.61%)

$159,817,000

Operating Expenses

$138,262,000 (-29.54%)

$196,238,000 (6.12%)

$184,923,000 (5.45%)

$175,365,000

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Income Tax Expense

$0 (0%)

$12,160,000 (148.98%)

$4,884,000 (7082.35%)

$68,000

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$128,514,000 (38.05%)

-$207,447,000 (-9.29%)

-$189,807,000 (-8.19%)

-$175,433,000

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$128,514,000 (38.05%)

-$207,447,000 (-9.29%)

-$189,807,000 (-8.19%)

-$175,433,000

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$128,514,000 (38.05%)

-$207,447,000 (-9.29%)

-$189,807,000 (-8.19%)

-$175,433,000

Weighted Average Shares

$16,954,577 (1.59%)

$16,689,740 (0.01%)

$16,688,128

-

Weighted Average Shares Diluted

$16,954,577 (1.59%)

$16,689,740

-

-

Earning Before Interest & Taxes (EBIT)

-$128,514,000 (34.19%)

-$195,287,000 (-5.60%)

-$184,923,000 (-5.45%)

-$175,365,000

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0

Operating Income

-$138,262,000 (29.54%)

-$196,238,000 (-6.12%)

-$184,923,000 (-5.45%)

-$175,365,000

MURA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$25,330,000 (-633.78%)

-$3,452,000 (37.36%)

-$5,511,000 (-25.68%)

-$4,385,000

Net Cash Flow from Financing

$196,000 (-99.96%)

$468,811,000 (169.28%)

$174,099,000 (8.10%)

$161,053,000

Net Cash Flow from Operations

-$128,545,000 (33.82%)

-$194,249,000 (-15.22%)

-$168,588,000 (-7.61%)

-$156,668,000

Net Cash Flow / Change in Cash & Cash Equivalents

-$153,679,000 (-156.69%)

$271,110,000 (0%)

$0 (0%)

$0

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

-$25,305,000 (0%)

$0 (0%)

$0 (0%)

$0

Capital Expenditure

-$25,000 (99.28%)

-$3,452,000 (37.36%)

-$5,511,000 (-25.68%)

-$4,385,000

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Issuance (Purchase) of Equity Shares

$196,000 (0%)

$0 (0%)

$0 (0%)

$0

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$5,081,000 (-78.92%)

$24,109,000 (102.07%)

$11,931,000 (3.71%)

$11,504,000

Depreciation Amortization & Accretion

$3,512,000 (36.81%)

$2,567,000 (66.69%)

$1,540,000 (4.48%)

$1,474,000

MURA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-68.20% (60.19%)

-171.30% (-117.84%)

960.20%

-

Return on Average Assets (ROAA)

-59.00% (52.30%)

-123.70% (77.56%)

-551.30%

-

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-145.60% (89.49%)

-1384.90% (-45.08%)

-954.60%

-

Dividend Yield

0% (0%)

0%

-

-

Price to Earnings Ratio (P/E)

-0.42 (10.71%)

-0.48

-

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.39 (4.27%)

0.38

-

-

Debt to Equity Ratio (D/E)

0.21 (43.06%)

0.14 (105.63%)

-2.56 (13.70%)

-2.96

Earnings Per Share (EPS)

-7.58 (39.02%)

-12.43

-

-

Sales Per Share (SPS)

0 (0%)

0 (0%)

0

-

Free Cash Flow Per Share (FCFPS)

-7.58 (35.99%)

-11.85 (-13.54%)

-10.43

-

Book Value Per Share (BVPS)

8.29 (-47.57%)

15.81 (1317.80%)

-1.3

-

Tangible Assets Book Value Per Share (TABVPS)

9.99 (-44.74%)

18.08 (794.16%)

2.02

-

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1

-

-

Enterprise Value Over EBITDA (EV/EBITDA)

0.39 (164.88%)

-0.6

-

-

Asset Turnover

0 (0%)

0 (0%)

0

-

Current Ratio

5.84 (-38.92%)

9.56 (8139.66%)

0.12 (-9.37%)

0.13

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$128,570,000 (34.97%)

-$197,701,000 (-13.56%)

-$174,099,000 (-8.10%)

-$161,053,000

Enterprise Value (EV)

-$48,506,802 (-142.08%)

$115,283,219

-

-

Earnings Before Tax (EBT)

-$128,514,000 (34.19%)

-$195,287,000 (-5.60%)

-$184,923,000 (-5.45%)

-$175,365,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$125,002,000 (35.14%)

-$192,720,000 (-5.09%)

-$183,383,000 (-5.46%)

-$173,891,000

Invested Capital

$33,790,000 (103.22%)

$16,627,000 (43.63%)

$11,576,000 (-57.39%)

$27,169,000

Working Capital

$126,722,000 (-48.97%)

$248,320,000 (775.83%)

-$36,743,000 (-26.67%)

-$29,008,000

Tangible Asset Value

$169,394,000 (-43.86%)

$301,745,000 (794.06%)

$33,750,000 (-3.87%)

$35,110,000

Market Capitalization

$54,934,198 (-44.40%)

$98,803,219

-

-

Average Equity

$188,535,750 (55.71%)

$121,080,500 (712.52%)

-$19,767,500

-

Average Assets

$217,775,000 (29.82%)

$167,747,500 (387.21%)

$34,430,000

-

Invested Capital Average

$88,261,750 (525.90%)

$14,101,500 (-27.21%)

$19,372,500

-

Shares

17,060,310 (2.22%)

16,689,733 (0.01%)

16,688,128

-